Michael G. McCully

Michael G. McCully has a diverse work experience in the biotech and pharmaceutical industry. Michael G. is the Co-Founder, President, and CEO of Gate Neurosciences, Inc., a company they started in 2018. Prior to that, they served as a Board Member and President at Anagin Inc. In 2017, they founded Terranova Bioventures, where they held the position of Managing Director, providing investment, strategic advisory, and transaction services to the industry. From 2016 to 2017, they worked as a Vice President at Locust Walk, where they provided strategic planning, negotiation, and alliance management to clients. Before that, they worked as a Managing Director at RedLeaf Bioventures LLC, providing advisory and consulting services for biotech, pharma, and med device companies. Notably, they served as the Chief Business Officer at Charleston Laboratories, Inc., leading a lucrative partnership deal resulting in a $650 million agreement with Daiichi Sankyo. Michael G. also held positions at Coherus Biosciences, Elan Pharmaceuticals, Deloitte, and Burrill & Company earlier in their career.

Michael G. McCully holds a Masters degree in Biotechnology & Business from Northwestern University. Michael G. also obtained a Bachelors degree in Plant Molecular Biology from Purdue University.